Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors
Tu, Wangyang; Yang, Fanglong; Xu, Guoji; Chi, Jiangtao; Liu, Zhiwei; Peng, Wei; Hu, Bing; Zhang, Lei; Wan, Hong; Yu, Nan; Jin, Fangfang; Hu, Qiyue; Zhang, Lianshan; He, Feng; Tao, Weikang Share Save Share Save Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's LymphomaLu, Biao; Shen, Xiaodong; Zhang, Lei; Liu, Dong; Zhang, Caihua; Cao, Jingsong; Shen, Ru; Zhang, Jiayin; Wang, Dan; Wan, Hong; Xu, Zhibin; Ho, Ming-Hsun; Zhang, Minsheng; Zhang, Lianshan; He, Feng; Tao, Weikang Share Save Discovery of EBI-1051: A novel and orally efficacious MEK inhibitor with benzofuran scaffoldLu, Biao; Huang, Song; Cao, Jingsong; Hu, Qiyue; Shen, Ru; Wan, Hong; Wang, Dan; Yuan, Jijun; Zhang, Lei; Zhang, Jiayin; Zhang, Minsheng; Tao, Weikang; Zhang, Lianshan Share Save Discovery of a novel and potent BRAF (V600E) inhibitor with a unique kinase targeting profile, EBI-907: Pharmacological characterization and potential to overcome drug resistance and paradoxical activationZhang, Jiayin; Liu, Dong; Shen, Ru; Yan, Yinfa; Yang, Liuqing; Zhang, Minsheng; Cao, Guoqing; Cao, Hu; Fu, Beibei; Gong, Aishen; Lu, Biao; Sun, Diming; Wan, Hong; Yan, Pangke; Zhang, Lei; Zhang, Lianshan; Cao, Jingsong Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
